Bell Therapeutics is a digital therapeutics (DTx) startup that treats diseases using real-time digital sound technology. BELL is developing next-generation digital therapeutics that implement the drug mechanism in software. It provides optimized solutions for patients by utilizing digital infrastructure such as smartphone sensors and cloud computing, and its mechanism of action is based on neuroscience mechanisms. The BELL team consists of experts in brain science, auditory neuroscience, music therapy, and music signal processing, and is preparing to enter the global medical market after successfully completing the efficacy clinical trial conducted at Seoul National University Hospital.